Ligand Pharmaceuticals Inc. (LGND)

NASDAQ: LGND · IEX Real-Time Price · USD
106.36
+4.39 (4.31%)
Aug 12, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012 2011 - 1994
Revenue
277.13186.42120.28251.45141.1108.9771.9164.5448.9731.39
Upgrade
Revenue Growth (YoY)
48.66%54.98%-52.16%78.21%29.48%51.53%11.43%31.78%56.03%4.50%
Upgrade
Cost of Revenue
62.1830.4211.356.345.375.575.819.145.733.6
Upgrade
Gross Profit
214.96156108.94245.12135.74103.466.1155.443.2427.79
Upgrade
Selling, General & Admin
57.4864.4441.8837.7328.6527.6525.422.5717.9815.78
Upgrade
Research & Development
69.0159.3955.9127.8626.8921.2211.019.759.2710.79
Upgrade
Other Operating Expenses
9.576.33-795.9315.7912.1210.642.383.461.041.02
Upgrade
Operating Expenses
136.06130.16-698.1481.3967.6659.5238.7835.7828.327.59
Upgrade
Operating Income
78.925.85807.08163.7368.0843.8927.3319.6314.940.19
Upgrade
Interest Expense / Income
19.6327.4235.7548.2813.4612.8411.84.862.082.92
Upgrade
Other Expense / Income
11.978.96-25.31-57.88-2.6222.35-22.182.331.07-1.01
Upgrade
Pretax Income
47.3-10.54796.64173.3357.238.6937.7112.4311.79-1.72
Upgrade
Income Tax
-9.84-7.55167.3430.0144.6810.33-192.120.410.37-1.19
Upgrade
Net Income
57.14-2.99629.3143.3212.56-1.64229.8212.0211.42-0.53
Upgrade
Net Income Common
57.14-2.99629.3143.3212.56-1.64229.8212.0211.42-0.53
Upgrade
Net Income Growth
--339.09%1041.45%--1811.38%5.29%--
Upgrade
Shares Outstanding (Basic)
17161921212120202020
Upgrade
Shares Outstanding (Diluted)
17162024232121212120
Upgrade
Shares Change
6.55%-18.08%-17.91%2.50%12.72%-1.87%-0.96%3.32%4.49%0.71%
Upgrade
EPS (Basic)
3.44-0.1833.136.770.60-0.0811.610.590.56-0.03
Upgrade
EPS (Diluted)
3.31-0.1831.855.960.53-0.0810.830.560.55-0.03
Upgrade
EPS Growth
--434.40%1024.53%--1833.93%1.82%--
Upgrade
Free Cash Flow Per Share
4.243.18-1.688.664.441.981.900.960.82-0.02
Upgrade
Gross Margin
77.60%83.70%90.60%97.50%96.20%94.90%91.90%85.80%88.30%88.50%
Upgrade
Operating Margin
28.50%13.90%671.00%65.10%48.20%40.30%38.00%30.40%30.50%0.60%
Upgrade
Profit Margin
20.60%-1.60%523.20%57.00%8.90%-1.50%319.60%18.60%23.30%-1.70%
Upgrade
Free Cash Flow Margin
25.50%27.60%-26.50%72.80%66.20%37.80%52.30%30.30%34.20%-1.30%
Upgrade
Effective Tax Rate
-20.80%71.67%21.01%17.31%78.06%118.82%-509.47%3.30%3.17%69.32%
Upgrade
EBITDA
117.8744.85876.12236.3282.4132.8252.1419.9516.533.93
Upgrade
EBITDA Margin
42.50%24.10%728.40%94.00%58.40%30.10%72.50%30.90%33.80%12.50%
Upgrade
Depreciation & Amortization
50.9527.9743.7314.7211.7111.292.632.662.662.73
Upgrade
EBIT
66.9216.88832.38221.6170.6921.5349.5117.2913.871.21
Upgrade
EBIT Margin
24.10%9.10%692.00%88.10%50.10%19.80%68.80%26.80%28.30%3.80%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).